| Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium TGM Van Erp, E Walton, DP Hibar, L Schmaal, W Jiang, DC Glahn, ... Biological psychiatry 84 (9), 644-654, 2018 | 775 | 2018 |
| The kynurenine pathway in schizophrenia and bipolar disorder S Erhardt, L Schwieler, S Imbeault, G Engberg Neuropharmacology 112, 297-306, 2017 | 255 | 2017 |
| Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia—significance for activation of the kynurenine pathway L Schwieler, MK Larsson, E Skogh, ME Kegel, F Orhan, S Abdelmoaty, ... Journal of Psychiatry and Neuroscience 40 (2), 126-133, 2015 | 245 | 2015 |
| The kynurenic acid hypothesis of schizophrenia S Erhardt, L Schwieler, L Nilsson, K Linderholm, G Engberg Physiology & behavior 92 (1-2), 203-209, 2007 | 210 | 2007 |
| Endogenous kynurenic acid disrupts prepulse inhibition S Erhardt, L Schwieler, C Emanuelsson, M Geyer Biological psychiatry 56 (4), 255-260, 2004 | 209 | 2004 |
| Imbalanced kynurenine pathway in schizophrenia ME Kegel, M Bhat, E Skogh, M Samuelsson, K Lundberg, ML Dahl, ... International Journal of Tryptophan Research 7, IJTR. S16800, 2014 | 125 | 2014 |
| Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area L Schwieler, KR Linderholm, LK Nilsson-Todd, S Erhardt, G Engberg Life sciences 83 (5-6), 170-175, 2008 | 107 | 2008 |
| Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients L Schwieler, M Samuelsson, MA Frye, M Bhat, I Schuppe-Koistinen, ... Journal of neuroinflammation 13, 1-10, 2016 | 105 | 2016 |
| Kynurenic acid and schizophrenia S Erhardt, L Schwieler, G Engberg Developments in Tryptophan and Serotonin Metabolism, 155-165, 2003 | 105 | 2003 |
| Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium E Walton, DP Hibar, TGM van Erp, SG Potkin, R Roiz‐Santiañez, ... Acta Psychiatrica Scandinavica 135 (5), 439-447, 2017 | 104 | 2017 |
| Prostaglandin-mediated control of rat brain kynurenic acid synthesis–opposite actions by COX-1 and COX-2 isoforms L Schwieler, S Erhardt, C Erhardt, G Engberg Journal of Neural Transmission 112, 863-872, 2005 | 101 | 2005 |
| Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine S Erhardt, L Schwieler, G Engberg Synapse 43 (4), 227-237, 2002 | 97 | 2002 |
| Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls M Holtze, P Saetre, G Engberg, L Schwieler, T Werge, OA Andreassen, ... Journal of Psychiatry and Neuroscience 37 (1), 53-57, 2012 | 89 | 2012 |
| Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex L Schwieler, G Engberg, S Erhardt Synapse 52 (2), 114-122, 2004 | 89 | 2004 |
| Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid A Atlas, M Gisslén, C Nordin, L Lindström, L Schwieler Brain, behavior, and immunity 21 (1), 86-91, 2007 | 73 | 2007 |
| The anaesthetic agent propofol interacts with GABAB-receptors: an electrophysiological study in rat L Schwieler, DS Delbro, G Engberg, S Erhardt Life sciences 72 (24), 2793-2801, 2003 | 70 | 2003 |
| Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls CM Sellgren, J Gracias, O Jungholm, RH Perlis, G Engberg, L Schwieler, ... Translational psychiatry 9 (1), 37, 2019 | 66 | 2019 |
| Peripheral and central kynurenine pathway abnormalities in major depression ER Paul, L Schwieler, S Erhardt, S Boda, A Trepci, R Kämpe, A Asratian, ... Brain, behavior, and immunity 101, 136-145, 2022 | 65 | 2022 |
| Effects of COX‐1 and COX‐2 inhibitors on the firing of rat midbrain dopaminergic neurons—Possible involvement of endogenous kynurenic acid L Schwieler, S Erhardt, L Nilsson, K Linderholm, G Engberg Synapse 59 (5), 290-298, 2006 | 64 | 2006 |
| Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia SK Olsson, AS Andersson, KR Linderholm, M Holtze, LK Nilsson-Todd, ... International Journal of Neuropsychopharmacology 12 (4), 501-512, 2009 | 59 | 2009 |
